-
Did you attend
@Xconomy: What’s Next in Neuroscience Therapies? Our CMO Jane Tiller MD and Kristina Burow of ARCH Venture Partners presented our approach leveraging computational and clinical neuroscience to develop targeted therapeutics for CNS disorders.#XconSF#Neuroscience pic.twitter.com/X0U6uYPgJu
-
At
@Xconomy’s What’s Next in Neuroscience, engage with scientists, entrepreneurs & other biotech leaders developing next-gen therapies/tech in spinal-cord injuries, mental health, addiction, dementia, Alzheimer's & more. Nov 19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/PCjHGV7AX1
-
Brain disorders are among the toughest to diagnose/treat, but new approaches/tech could change everything. Join
@Xconomy,@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews & more for What’s Next in Neuroscience - 11/19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/jDII8kvS2R
-
Sign up for our new free newsletters for industry news, insight, and analysis: https://mailchi.mp/xconomy.com/subscribe-twitter-profile …
#Xconomists#XconXpertise#XconBioRoundup#XcelerateLS#XconSD#XconSF#XconNY#XconBOS#XconSEA#XconPHIpic.twitter.com/BW5Oav6cRA
-
Insight from experts such as
@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews,@aiforia_tech & more: https://xconomy.com/xpertise/whats-next-neuroscience-therapies/ …#XconSF pic.twitter.com/ww7EqQ9z5R
-
See you tomorrow! Explore new tech changing how we understand brain diseases/spinal injuries & novel approaches companies are taking to treat these conditions: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum/ …
#XconSF pic.twitter.com/E55uOt2OLD
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.